Tower Research Capital LLC (TRC) - NEXIMMUNE INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$1,342
-25.6%
6,390
-0.0%
0.00%
Q2 2023$1,803
+90050.0%
6,392
-1.9%
0.00%
Q1 2023$20.0%6,515
-0.3%
0.00%
Q4 2022$2
-100.0%
6,534
-53.1%
0.00%
Q3 2022$8,000
+14.3%
13,921
+219.8%
0.00%
Q2 2022$7,000
-73.1%
4,353
-28.9%
0.00%
Q1 2022$26,000
+100.0%
6,122
+116.5%
0.00%
Q4 2021$13,000
+62.5%
2,828
+443.8%
0.00%
Q3 2021$8,000
-63.6%
520
-62.2%
0.00%
-100.0%
Q2 2021$22,000
+340.0%
1,377
+473.8%
0.00%
Q1 2021$5,0002400.00%
Other shareholders
NEXIMMUNE INC shareholders Q4 2023
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 390,600$81,9870.04%
M28 Capital Management LP 133,442$28,0090.03%
ALLEN OPERATIONS LLC 635,934$133,5460.03%
Slate Path Capital LP 925,000$194,1580.01%
Caprock Group, LLC 103,482$21,7210.00%
WELLS FARGO & COMPANY/MN 126$260.00%
NORTHERN TRUST CORP 12,668$2,6590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 108,143$21,6280.00%
STATE STREET CORP 22,919$4,5840.00%
View complete list of NEXIMMUNE INC shareholders